Alteplase for thrombolysis in acute ischemic stroke.
D000208:Acute Disease; D002545:Brain Ischemia / Q000188:drug therapy / Q000191:economics; D002543:Cerebral Hemorrhage / Q000139:chemically induced / Q000209:etiology; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000191:economics; D000075202:Contraindications; D017281:Cost of Illness; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D010919:Placebos; D013300:Streptokinase / Q000008:administration & dosage / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010919:Placebos; D013300:Streptokinase; D010959:Tissue Plasminogen Activator